Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
IOVA

Iovance Biotherapeutics

$8.35

0.2 (2.45%)

07:19
01/08/18
01/08
07:19
01/08/18
07:19
Hot Stocks
Iovance to 'vigorously defend' against shareholder derivative complaint »

Iovance Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IOVA

Iovance Biotherapeutics

$8.35

0.2 (2.45%)

04:55
01/07/18
01/07
04:55
01/07/18
04:55
Conference/Events
Iovance Biotherapeutics management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

IOVA

Iovance Biotherapeutics

$8.20

0.1 (1.23%)

10:11
01/04/18
01/04
10:11
01/04/18
10:11
Conference/Events
Iovance Biotherapeutics management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

IOVA

Iovance Biotherapeutics

$8.30

0.3 (3.75%)

17:21
12/28/17
12/28
17:21
12/28/17
17:21
Syndicate
Breaking Syndicate news story on Iovance Biotherapeutics »

Iovance Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

Over a month ago
IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

08:55
12/13/17
12/13
08:55
12/13/17
08:55
Conference/Events
Iovance Biotherapeutics to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

, AZN

AstraZeneca

$33.42

0.3 (0.91%)

07:08
12/13/17
12/13
07:08
12/13/17
07:08
Hot Stocks
Iovance Biotherapeutics expands pipeline of TIL therapies into lung cancer »

Iovance Biotherapeutics…

IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

AZN

AstraZeneca

$33.42

0.3 (0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BLFS

BioLife Solutions

$5.44

-0.13 (-2.33%)

, IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

06:39
12/13/17
12/13
06:39
12/13/17
06:39
Hot Stocks
BioLife Solutions executes supply agreement with Iovance Biotherapeutics »

BioLife Solutions (BLFS)…

BLFS

BioLife Solutions

$5.44

-0.13 (-2.33%)

IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IOVA

Iovance Biotherapeutics

$8.90

0.05 (0.56%)

04:55
12/13/17
12/13
04:55
12/13/17
04:55
Conference/Events
Iovance Biotherapeutics to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IOVA

Iovance Biotherapeutics

$8.85

0.1 (1.14%)

13:56
12/12/17
12/12
13:56
12/12/17
13:56
Conference/Events
Iovance Biotherapeutics to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

IOVA

Iovance Biotherapeutics

$7.85

0.625 (8.65%)

05:34
11/10/17
11/10
05:34
11/10/17
05:34
Hot Stocks
Iovance announced new LN-144 Phase 2 data in metastatic melanoma »

Iovance Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 15

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.